Drug Shortage Report for DUPIXENT
| Report ID | 159319 |
| Drug Identification Number | 02470365 |
| Brand name | DUPIXENT |
| Common or Proper name | dupilumab injection 300 mg single-use syringe |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DUPILUMAB |
| Strength(s) | 150MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 300 mg/2 mL |
| ATC code | D11AH |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-04-25 |
| Actual start date | |
| Estimated end date | 2022-05-06 |
| Actual end date | 2022-04-28 |
| Shortage status | Resolved |
| Updated date | 2022-05-02 |
| Company comments | The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-05-02 | French | Compare |
| v4 | 2022-05-02 | English | Compare |
| v3 | 2022-04-26 | English | Compare |
| v2 | 2022-04-22 | French | Compare |
| v1 | 2022-04-22 | English | Compare |
Showing 1 to 5 of 5